Adenosine deaminase deficiency: Unanticipated benefits from the study of a rare immunodeficiency

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 933-935

  Blackburn, Michael R ^a   Thompson, Linda F ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; PEGADEMASE;

ADENOSINE DEAMINASE DEFICIENCY; ADENOSINE DEAMINASE GENE; DISEASE ASSOCIATION; ENZYME REPLACEMENT; ERYTHROCYTE TRANSFUSION; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; HOUSEKEEPING GENE; HUMAN; IMMUNE RESPONSE GENE; IMMUNOPATHOGENESIS; MOLECULAR PATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; TISSUE DISTRIBUTION;

ADENOSINE DEAMINASE; AGAMMAGLOBULINEMIA; FEMALE; HUMANS; IMMUNITY, CELLULAR; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84856569669     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103519     Document Type: Note

References (24)

1. Giblett, E. R., J. E. Anderson, F. Cohen, B. Pollara, and H. J. Meuwissen. 1972. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2: 1067-1069.
2. Seegmiller, J. E., F. M. Rosenbloom, and W. N. Kelley. 1967. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155: 1682-1684.
3. Thompson, L. F., and J. E. Seegmiller. 1980. Adenosine deaminase deficiency and severe combined immunodeficiency disease. In Advances in Enzymology, Vol. 51. A. Meister, ed. John Wiley and Sons, Chichester, England, p. 167-210.
4. Giblett, E. R., A. J. Ammann, D. W. Wara, R. Sandman, and L. K. Diamond. 1975. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet 1: 1010-1013.
5. Polmar, S. H., E. M. Wetzler, R. C. Stern, and R. Hirschhorn. 1975. Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet 2: 743-746.
6. Coleman, M. S., J. Donofrio, J. J. Hutton, L. Hahn, A. Daoud, B. Lampkin, and J. Dyminski. 1978. Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency. J. Biol. Chem. 253: 1619-1626. (Pubitemid 8312340)
7. Cohen, A., R. Hirschhorn, S. D. Horowitz, A. Rubinstein, S. H. Polmar, R. Hong, and D. W. Martin, Jr. 1978. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc. Natl. Acad. Sci. USA 75: 472-476. (Pubitemid 8287550)
8. Carson, D. A., J. Kaye, and J. E. Seegmiller. 1977. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc. Natl. Acad. Sci. USA 74: 5677-5681.
9. Van De Wiele, C. J., J. G. Vaughn, M. R. Blackburn, C. A. Ledent, M. Jacobson, H. Jiang, and L. F. Thompson. 2002. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation. J. Clin. Invest. 110: 395-402. (Pubitemid 34847972)
10. Golomb, H. M. 2011. Fifty years of hairy cell leukemia treatments. Leuk. Lymphoma 52(Suppl 2): 3-5.
11. Hershfield, M. S., R. H. Buckley, M. L. Greenberg, A. L. Melton, R. Schiff, C. Hatem, J. Kurtzberg, M. L. Markert, R. H. Kobayashi, A. L. Kobayashi, and A. Abuchowski. 1987. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N. Engl. J. Med. 316: 589-596. (Pubitemid 17024481)
12. Jevsevar, S., M. Kunstelj, and V. G. Porekar. 2010. PEGylation of therapeutic proteins. Biotechnol. J. 5: 113-128.
13. Jenkins, T., A. R. Rabson, G. T. Nurse, and A. B. Lane. 1976. Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J. Pediatr. 89: 732-736.
14. Kohn, D. B., M. S. Hershfield, D. Carbonaro, A. Shigeoka, J. Brooks, E. M. Smogorzewska, L. W. Barsky, R. Chan, F. Burotto, G. Annett, et al. 1998. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat. Med. 4: 775-780. (Pubitemid 28331017)
15. Cavazzana-Calvo, M., S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, et al. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672. (Pubitemid 30241569)
16. Aiuti, A., F. Cattaneo, S. Galimberti, U. Benninghoff, B. Cassani, L. Callegaro, S. Scaramuzza, G. Andolfi, M. Mirolo, I. Brigida, et al. 2009. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 360: 447-458.
17. Wakamiya, M., M. R. Blackburn, R. Jurecic, M. J. McArthur, R. S. Geske, J. Cartwright, Jr., K. Mitani, S. Vaishnav, J. W. Belmont, R. E. Kellems, et al. 1995. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci. USA 92: 3673-3677.
18. Migchielsen, A. A. J., M. L. Breuer, M. A. van Roon, H. te Riele, C. Zurcher, F. Ossendorp, S. Toutain, M. S. Hershfield, A. Berns, and D. Valerio. 1995. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat. Genet. 10: 279-287.
19. Blackburn, M. R., S. K. Datta, and R. E. Kellems. 1998. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J. Biol. Chem. 273: 5093-5100. (Pubitemid 28108669)
20. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170. (Pubitemid 30470299)
21. Blackburn, M. R., M. Aldrich, J. B. Volmer, W. Chen, H. Zhong, S. Kelly, M. S. Hershfield, S. K. Datta, and R. E. Kellems. 2000. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J. Biol. Chem. 275: 32114-32121.
22. Zhou, Y., D. J. Schneider, and M. R. Blackburn. 2009. Adenosine signaling and the regulation of chronic lung disease. Pharmacol. Ther. 123: 105-116.
23. Gessi, S., S. Merighi, K. Varani, and P. A. Borea. 2011. Adenosine receptors in health and disease. Adv. Pharmacol. 61: 41-75.
24. Mi, T., S. Abbasi, H. Zhang, K. Uray, J. L. Chunn, L. W. Xia, J. G. Molina, N. W. Weisbrodt, R. E. Kellems, M. R. Blackburn, and Y. Xia. 2008. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J. Clin. Invest. 118: 1491-1501. (Pubitemid 351500442)